Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen. Ibrahim M, Chen R, Vegel A, Panse K, et al. Leuk Res 2021;106:106583.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ibrahim M, Chen R, Vegel A, Panse K, et al. Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen. Leuk Res 2021;106:106583.
PMID: 33906021